2012-000152-34: valuation of the effect of a new drug for diabetes on atherosclerosis in patients with primary failure metformin valutazione dell'effetto di un nuovo farmaco per il diabete sull'aterosclerosi in pazienti in fallimento primario con metformina |
|
|
| Ongoing | 4 | 64 | Europe | Film-coated tablet, JANUVIA*28CPR RIV 100MG | AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA, azienda policlinico umberto I | Type 2 diabetes Diabete mellito tipo 2, Type 2 diabetes Diabete tipo 2, Diseases [C] - Hormonal diseases [C19] | | | | |
2010-019346-11: Effects of vildagliptin twice daily vs. sitagliptin once daily on reduction of oxidative stress and inflammation by blunting interprandial acute glucose fluctuations in patients with type 2 diabetes - PROBE Design (Multicenter Prospective, Randomized, Open-label parallel group with a blinded-endpoint) Effetti di vildagliptin(50 mg x 2/die) vs sitagliptin (100 mg/die) sullo stress ossidativo e sull\'infiammazione in relazione alle fluttuazioni glicemiche interprandiali in pazienti con diabete mellito tipo 2 - PROBE Design (Multicenter Prospective, Randomized, Open-label parallel group with a blinded-endpoint) |
|
|
| Ongoing | 4 | 90 | Europe | Tablet | AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA\' DEGLI STUDI DI NAPOLI | patients with type 2 diabetes poorly controlled PAZIENTI DIABETICI SCOMPENSATI | | | | |
SiCa-Flam, NCT05725798: Perioperative Sitagliptin Medication for Reduction of the Inflammatory Response Associated With Cardiopulmonary Bypass |
|
|
| Completed | N/A | 20 | Europe | Sitagliptin | University Hospital Muenster | Systemic Inflammatory Response Syndrome | 05/23 | 08/23 | | |
